Hans Hull Insider Trading $PLRX PLIANT THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hans Hull.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hans Hull. Hans Hull is Chief Executive Officer in Adverum Biotechnologies, Inc. ($AAVL) and SVP, Business Operations in Adverum Biotechnologies, Inc. ($AAVL) and SVP, Legal and Corp. Dev. in Adverum Biotechnologies, Inc. ($AAVL) and Chief Business Officer in PLIANT THERAPEUTICS, INC. ($PLRX).
Hans Hull in PLIANT THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Hans Hull: Chief Business Officer
Holdings: 125,246 shares
Latest Transaction: May 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Hans Hull in PLIANT THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | M | 2.08 | 4,500 | 9,360 | 12,979 | |
| May 28 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | M | 2.08 | 4,500 | 9,360 | 125,246 | 120.7 K to 125.2 K (+3.73 %) |
| Jan 26 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | A | 26.50 | 62,250 | 1,649,625 | 62,250 | |
| Jan 04 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | M | 2.08 | 3,500 | 7,280 | 17,479 | |
| Jan 04 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | M | 2.08 | 3,500 | 7,280 | 120,746 | 117.2 K to 120.7 K (+2.99 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | C | 0.00 | 27,322 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | C | 0.00 | 27,322 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | C | 0.00 | 36,319 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | C | 0.00 | 36,319 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | A | 6.22 | 70,352 | 437,589 | 70,352 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | A | 6.22 | 70,352 | 437,589 | 70,352 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | A | 0.00 | 27,322 | 0 | 27,322 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | A | 0.00 | 27,322 | 0 | 27,322 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | C | 0.00 | 3,821 | 0 | 3,821 | 0 to 3.8 K |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | C | 0.00 | 3,821 | 0 | 3,821 | 0 to 3.8 K |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | C | 0.00 | 5,079 | 0 | 117,246 | 112.2 K to 117.2 K (+4.53 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | C | 0.00 | 5,079 | 0 | 117,246 | 112.2 K to 117.2 K (+4.53 %) |
Page: 1